<qa>  What is the STUDY of ROTIGOTINE?A PHASE 3B, OPEN-LABEL, SAFETY AND EFFICACY STUDY OF ROTIGOTINE AS ADD-ON THERAPY WITH LOW DOSES OF PRAMIPEXOLE OR ROPINIROLE IN PATIENTS WITH ADVANCED PARKINSONS DISEASE: 